期刊文献+

硝呋太尔制霉素阴道软胶囊治疗妊娠期阴道炎的临床观察 被引量:11

Effect of nifutatel and nysfungin vaginal soft capsules on treatment of vulvovaginal infections in pregnancy
原文传递
导出
摘要 目的评价硝呋太尔制霉素阴道软胶囊治疗妊娠期阴道炎包括外阴阴道假丝酵母菌性阴道炎、滴虫性阴道炎、细菌性阴道炎以及非特异性阴道炎的临床疗效。方法对妊娠28-32周的孕妇中105例患外阴阴道假丝酵母菌性阴道炎30例、滴虫性阴道炎25例、细菌性阴道炎20例、非特异性外阴阴道炎者30例,采用硝呋太尔制霉素阴道软胶囊治疗观察疗效。结果硝呋太尔制霉素阴道软胶囊可改善临床症状,总有效率91.4%。结论硝呋太尔制霉素阴道软胶囊可作为治疗妊娠期阴道炎的阴道局部用药。 Objective To evaluate the effect of nifutatel and nysfungin vaginal soft capsules on treat ment of vulvovaginal infections in pregnancy, including triehomoniasis, vulvovaginal candidiasis( VVC), bacterial vaginosis(BV) and nonspecifie vaginal infections. Methods Nifutatel and nysfungin vaginal soft capsules was given the pregnant women with trichomoniasis ( n = 25), VVC( n =30) , BV ( n =20) or uonspecifie vaginal infections ( n =25). Results Nifutatel and nysfungin vaginal soft capsules can allivate symptoms, and the effective rate was 91.4%. Conclusion Nifutatel and nysfungin vaginal soft capsules can be an option in treat ment of vulvovaginal infections in pregnancy.
出处 《临床医学》 CAS 2008年第11期30-31,共2页 Clinical Medicine
关键词 硝呋太尔制霉素阴道软胶囊 妊娠 外阴阴道假丝酵母菌性阴道炎 滴虫性阴道炎 细菌性阴道炎 非特异性外阴阴道炎 Nifutatel and nysfungin vaginal soft capsules Pregnancy Trichomoniasis Vulvovaginal candidiasis Bacterialvaginosis Nonspecific vaginal infections
  • 相关文献

参考文献3

  • 1耿力,宋学红,郝增平,陈蕾,詹宇新,朱馥丽,刘军,唐学磊,杨惠静.国产硝呋太尔制霉素阴道软胶囊治疗阴道炎的临床研究[J].中国妇产科临床杂志,2007,8(1):26-29. 被引量:52
  • 2De - Seta F, Sartore A, Piccoli M. Bacterial vaginosis and preterm delivery : an open question [ J ]. J Reprod Med, 2005,50 : 313 - 318.
  • 3Mending W, Poli A, Magnani P. Clinical effects of nifuratel in vulvovaginal infections. A meta - analsis of metronidazole - controlled trias[ J ]. Arzneim Forsch Drug Res,2002,52:725 - 730.

二级参考文献8

  • 1沈汝棡,聂妍,何芳,刘凯波,李禾,丁辉.北京市围产期妇女生殖道感染监测与分析[J].中华围产医学杂志,2004,7(5):259-261. 被引量:12
  • 2[1]Pal Z,Dosa E,Pal A.Bacterial vaginosis and other vaginal infections.Int J Gynaecol Obstet,2005,89:278-279.
  • 3[2]Ries AJ.Treatment of vaginal infections:candidiasis,bacterial vaginosis,and trichomoniasis.J Am Pharma Assoc,1997,NS37:563-569.
  • 4[3]Polatti F,Nappi RE,Brundu B,et al.Clinical study on the dose-effect relationship of a Nifuratel-Nystatin combination in the treatment of vulvovaginal infections.Arzneim Forsch Drug Res,2003,53:730-737.
  • 5[5]De-Seta F,Sartore A,Piccoli M.Bacterial vaginosis and preterm delivery:an open question.J Reprod Med,2005,50:313-318.
  • 6[6]El-Din SS,Reynolds MT,Ashbee HR.Investigation into the pathogenesis of vulvo-vaginal candidosis.Sex Transm Infect,2001,77:179-183.
  • 7[7]Parazzini F,Cintio E,Chianten V,et al.Determinants of different candida species infections of the genital tract in women,Sporachrom Study Group.Eur J Obstet Gynecol Reprod Biol,2002,93:141-145.
  • 8[8]Mendling W,Poli A,Magnani P.Clinical effects of nifuratel in vulvovaginal infections.A meta-analysis of metronidazole -controlled trials.Arzneim Forsch Drug Res,2002,52:725-730.

共引文献51

同被引文献52

引证文献11

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部